483 GlaxoSmithKline Research & Development Dec 2009

483 GlaxoSmithKline Research & Development Dec 2009

Yumi Hiramine FDA$119.00 - Available Now

FDA investigators audited the GlaxoSmithKline Research & Development - Stevenage, United Kingdom facility and issued inspectional observations (via FDA 483) on 17 Dec 2009.

Product details

  • Category: Human Drugs
  • Inspection end: 17 Dec 2009
  • Location: Stevenage, United Kingdom
  • FEI: 3003284850
Add To Cart